Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice

British Journal of Pharmacology

Volumn 123, Issue 4, 1998, Pages 625-630

  Su, Mei Tsu ^a   Lin, Wei Bin ^a   Lue, Wei Ming ^a   Cheng, Chen Yu ^b   Tao, Pao Luh ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

MK 801; Morphine; N methyl D aspartate; Opioid receptor; Tolerance; U 50,488; Vasopressin

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; AMINO ACID RECEPTOR BLOCKING AGENT; ARGIPRESSIN; ARGIPRESSIN, DEAMINOPENICILLAMINE(1) O METHYL TYR(2); ARGIPRESSIN, DEAMINOPENICILLAMINE(1)-O-METHYL-TYR(2)-; DIZOCILPINE MALEATE; DRUG DERIVATIVE; KAPPA OPIATE RECEPTOR; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VASOPRESSIN RECEPTOR;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; DRUG TOLERANCE; EVOKED RESPONSE; HIPPOCAMPUS; IN VITRO STUDY; MALE; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; ARGININE VASOPRESSIN; DIZOCILPINE MALEATE; DRUG TOLERANCE; EVOKED POTENTIALS; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; MALE; MORPHINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, KAPPA; RECEPTORS, VASOPRESSIN;

EID: 0031990460     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701646     Document Type: Article

References (37)

1. ACETO, M.D., DEWEY, W.L., CHANG, J.K. & LEE, N.M. (1982). Dynorphin-(1-13): effects in nontolerant and morphine-dependent rhesus monkeys. Eur. J. Pharmacol., 83, 139 - 142.
2. BREDT, D.S. & SNYDER, S.H. (1989). Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A., 86, 9030 - 9033.
3. BREDT, D.S. & SNYDER, S.H. (1992). Nitric oxide, a novel neuronal messenger. Neuron, 8, 3 - 11.
4. DUNWIDDIE, T., JOHNSON, K.J. & PROCTER, W.R. (1987). Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus. Br. J. Pharmacol., 91, 523 - 530.
5. DUNWIDDIE, T. & LYNCH, G. (1978). Long-term potentiation and depression of synaptic responses in the rat hippocampus: localization and frequency dependency. J. Physiol., 276, 353 - 367.
6. FIREMARK, H.M. & WEITZMAN, R.E. (1979). Effect of β-endorphin, morphine, and naloxone on arginine vasopressin secretion and the electroencephalogram. Neuroscience, 4, 1895 - 1902.
7. GARTHWAITE, J., GARTHWAITE, G., PLAMER, R.M.J. & MONCADA, S. (1989). NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol., 172, 413 - 416.
8. GREEN, P.G. & LEE, N.M. (1988). Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration. Eur. J. Pharmacol., 145, 267 - 272.
9. GREENAMYRE, J.T., OLSON, J.M.M., PENNEY, Jr, J.B. & YOUNG, A.B. (1985). Autoradiographic characterization of N-methyl-D-aspartate-. quisqualate- and kainate-sensitive glutamate binding sites. J. Pharmacol. Exp. Ther., 233, 254 - 263.
10. GUITART, X. & NESTLER, E.J. (1993). Second messenger and protein phosphorylation mechanisms underlying opiate addiction: studies in the rat locus coeruleus. Neurochem. Res., 18, 5 - 13.
11. HOOKE, L.P., HE, L. & LEE, N.M. (1995). Dynorphin A modulates acute and chronic opioid effects. J. Pharmacol. Exp. Ther., 273, 292 - 297.
12. HUIDOBRO-TORO, J.P., YOSHIMURA, K., LEE, N.M., LOH, H.H. & WAY, E.L. (1981). Dynorphin interaction at the kappa-opiate site. Eur. J. Pharmacol., 72, 265 - 266.
13. G-Nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol., 221, 399 - 400.
14. LEANDER, J.D., HART, J.C. & ZERBE, R.L. (1987). Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels. J. Pharmacol. Exp. Ther., 242, 33 - 39.
15. LING, G.S.F., PAUL, D., SIMANTOV, R. & PASTERNAK, G.W. (1989). Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model. Life Sci., 45, 1627 - 1636.
16. MAJEED, N.H., PRZEWLOCKA, B., MACHELSKA, H. & PRZEWLOCKA, R. (1994). Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacotogy, 33, 189 - 192.
17. MANSOUR, A., KHACHATURIAN, H., LEWIS, M.E., AKIL, H. & WATSON, S.J. (1987). Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forbrain and midbrain. J. Neurosci., 7, 2445 - 2464.
18. MAREK, P., BEN-ELIYAHU, S., VACCARINO, A.L. & LIEBESKIND, J.C. (1991). Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res., 558, 163 - 165.
19. NYLANDER, I., VLASKOVSKA, M. & TERENIUS, L. (1995). The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems, in Sprague-Dawley rats. Psychopharmacology, 118, 391 - 400.
20. PHILLIPS, P.A., ABRAHAMS, J.M., KELLY, J., PAXINOS, G., GRZONKA, Z., MENDELSOHN, F.A. & JOHNSTON, C.I. (1988). Localization of vasopressin binding sites in rat brain by in vitro autoradiography using a radioiodinated VI receptor antagonist. Neuroscience, 27, 749 - 761.
21. PORTOGHESE, P.S. & LIPKOWSKI, A.W. (1987). Substituted pyrroles with opioid receptor activity. U.S. Patent 4 649 200. Chem. Abstr., 107, 40175.
22. PORTOGHESE, P.S., LIPKOWSKI, A.W. & TAKEMORI, A.E. (1987). Bimorphinans as highly selective, potent κ opioid receptor antagonists. J. Med. Chem., 30, 238 - 239.
23. SUZUKI, T., NARITA, M., TAKAHASHI, Y., MISAWA, M. & NAGASE, H. (1992). Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine. Eur. J. Pharmacol., 213, 91 - 97.
24. SZMUSZKOVICZ, J. (1979). 2-Aminocycloaliphatic amide compounds. US Pat. 4,145,435. Chem. Abstr., 91, 39003g.
25. SZMUSZKOVICZ, J. & VON VOIGTLANDER, P.F. (1982). Benzene-acetamide amines: structurally novel non-mu opioids. J. Med. Chem., 25, 1125 - 1126.
26. TAKAHASHI, M., SENDA, T. & KANETO, H. (1991). Role of spinal κ opioid receptors in the blockade of the development of antinociceptive tolerance to morphine. Eur. J. Pharmacol., 200, 293 - 297.
27. TAKEMORI, A.E., LOH, H.H. & LEE, N.M. (1992). Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice. Eur. J. Pharmacol., 221, 223 - 226.
28. 1] dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice. J. Pharmacol. Exp. Ther., 266, 121 - 124.
29. TAO, P.-L., HWANG, C.-L. & CHEN. C.-Y. (1994). U-50, 488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs. Eur. J. Pharmacol., 256, 281 - 286.
30. TAO, P-L., LEE, C-R., LAW, P.-Y. & LOH, H.H. (1993). The interaction of the α-opioid receptor and G protein is altered after chronic morphine treatment in rats. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 504 - 508.
31. TAO, P.-L., LIU, W.-C., TSUEI, Y.-S. & CHEN, C.-Y. (1997). The role of vasopressin on the effect of U-50,488 to block the development of morphine tolerance and physical dependence, Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 281 - 297.
32. TISEO, P.J. & INTURRISI, C.E. (1993). Attenuation and reversal of morphine tolerance by the competitive N-Methyl-D-Aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther., 264, 1090 - 1096.
33. TRUJILLO, K.A. & AKIL, H. (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 251, 85 - 87.
34. WEN, H.L. & HO, W.K.K. (1982). Suppression of withdrawal symptoms by dynorphin in heroin addicts. Eur. J. Pharmacol., 82, 183 - 186.
35. XU, Q., TAKAHASHI, M. & KANETO, H. (1992). Dependency on the brain function of arginine vasopressin system of the development to and recovery from analgesic tolerance to morphine. Brain Res., 577, 189 - 193.
36. YAMAMOTO, T., OHNO, M. & UEKI, S. (1988). A selective κ-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats. Eur. J. Pharmacol., 156, 173 - 176.
37. YUKHANANOVA, R.Y., ZHAI, Q.Z., PERSSON, S., POST, C. & NYBERG, F. (1993). Chronic administration of morphine decreases level of dynorphin a in the rat nucleus accumbens. Neuropharmacology, 32, 703 - 709.